Objective: To establish the prevalence of intrahepatic cholestasis of pregnancy (ICP) in a primarily Latina population in the United States.
Introduction
Intrahepatic cholestasis of pregnancy (ICP) is a condition of total body pruritus and is usually encountered late in pregnancy. ICP is associated with poor obstetric and fetal outcomes such as preterm labor (19 to 60%), meconium passage (30%) and fetal death (1 to 7%). [1] [2] [3] Several different measures of liver dysfunction have been reported in ICP, including elevated transaminases, bilirubin, gamma-glutamyl transpeptidase and serum bile acid concentration. The most commonly accepted laboratory criterion for ICP is an elevated total serum bile acid concentration. 4 The exact pathophysiologic mechanisms leading to poor obstetric and fetal outcomes seen in ICP are unknown; however, dysfunctional serum bile acid metabolism may play a central role. Higher total serum bile acid levels are associated with higher rates of fetal complications, although adverse outcomes have been reported in patients receiving treatment that effectively lowered total serum bile acids to normal. 5 The prevalence of this disorder varies throughout the world. There is a high prevalence in Latin America. In Chile, rates have varied from 4 to 22%, 6, 7 and in Bolivia rates of ICP are 9%. 8 In Caucasian populations, the prevalence of ICP is lower. Authors from Scandinavian countries report a prevalence of approximately 2%. 4, 9 Rates from France and the United Kingdom are less than 1%. 10 The prevalence of ICP in the United States has been reported from two studies to be between 0.001 and 0.32%. 10, 11 The reported low prevalence in the United States is contrary to our clinical observation of treating ICP at the University of Southern California in Los Angeles. To our knowledge, there is no prevalence data on ICP in the Latina population based in the United States.
One problem with determining prevalence of ICP is the lack of consistent diagnostic criteria. The diagnosis is commonly made on the clinical basis of pruritus without a rash after having excluded other dermatoses of pregnancy. In addition, a component of biliary obstruction is also usually required by most investigators, which may involve laboratory evidence such as an elevation in serum bile acids, transaminases and/or alkaline phosphatase. Of these laboratory parameters, total serum bile acids have been noted to be the first to rise and have the highest degree of sensitivity. 12 Our current method of diagnosing ICP at our institution includes the presence of itching in the absence of a rash with elevated total serum bile acids. The purpose of this study is to establish the prevalence of ICP in a primarily Latina population based in Los Angeles, California. In addition, we sought to examine the predictive value of a pruritis scale for the diagnosis of ICP.
Materials and methods
Patients were prospectively enrolled at the LAC-USC Women's and Children's Hospital from July 1997 to November 1998. Subjects with pregnancies admitted to Labor and Delivery and undergoing labor were enrolled. Inclusion criteria for our study included: age X18 years old, pregnancy in the third trimester and ability to provide informed consent. Exclusion criteria for our study were the presence of pre-existing liver disease (such as hepatitis B and C, primary biliary cirrhosis, familial cholestatic liver disease) and the inability to provide informed consent. Enrollment of subjects occurred Monday to Friday between the hours of 0800 to 1700. Subjects were asked to rank their degree of pruritus on a visual analog scale from 1 to 10 (1 ¼ no itching, 10 ¼ intolerable itching). A pruritus score, which directly corresponds to the numerical value placed on the visual analog scale, was given to each subject. Following completion of the questionnaire, peripheral venous blood samples were obtained to evaluate total serum bile acid concentration by radioimmunoassay. We defined ICP as the combination of pruritus score >4 and a total elevated total serum bile acid level X20 mmol/l. The pruritus criteria of a score >4 were initially arbitrarily set as a value to represent a moderate degree of itching. Subjects who did not complain of pruritus but had elevated serum bile acids were not considered as having ICP because there would have been no clinical symptoms to initially suspect ICP and thus negate the necessity to order total serum bile acids. Our total serum bile acid concentration cutoff was based on our laboratory's total serum bile acid upper limit 95% reference range at the time of the study. Ethnicity was determined by hospital record demographic information. This study was approved by the LAC-USC Institutional Review Board.
In order to analyze whether the degree of pruritus makes a difference in determining elevated bile acids, we evaluated the screening characteristics and predictive values of the pruritus scale using two different threshold for the pruritus score -any pruritus (score >1) and moderately aggravating pruritus (score >4), the criteria used for our study. In addition, we evaluated the characteristics of the pruritus scale to predict ICP at a lower total serum bile acid threshold (X15 mmol/l). Using the best criteria to diagnose ICP based on these data maternal characteristics and obstetric outcomes were compared between the subjects with ICP to those without ICP using w 2 for proportions, Student's t-test for means and Mann-Whitney U for medians. Multiple logistic regression was used to assess ICP as a predictor for obstetric outcomes. Statistical significance was defined as a P<0.05 and a statistical trend was identified with P>0.05 and <0.10.
Results
A total of 340 subjects were enrolled. All subjects asked to participate in the study accepted. There was no difference between our subjects with and without ICP with regards to maternal age, gravidity and parity. Subjects with ICP were enrolled at a slightly earlier gestational age (39.1 vs 37.5 weeks, P<0.01).
The range of serum bile acid concentration for the entire study population was 1 to 580 mmol/l with a mean of 10.4±34.9 mmol/l. Twenty-four (7.1%) subjects had a serum bile acid concentration X20 mmol/l. A pruritus score >4 was found in 19.7% (67/340) of the total study population. Of the 24 subjects with a bile acid concentration X20 mmol/l, 19 also had a pruritus score >4 (Table 1) . Based on these results, in our population the prevalence ICP is 5.6% (19/340). Latinas consisted of 93% (316/340) of our Table 1 Maternal demographics, serum bile acid concentrations and pruritus score values comparing normal pregnancies to those with ICP defined as pruritus score >4 and total serum bile acid concentration X20 mmol/l Table 1 ). The sensitivity, specificity, positive predictive value and negative predictive value of the pruritis scale to predict a bile acid level X20 mmol/l for a pruritus score greater than 1 were 91.7, 66.1, 17.1 and 99.1%, respectively. The area beneath the receiver operating characteristic curve for the pruritus scale to predict a bile acid level X20 mmol/l was 0.897. For patients with the worst itching (pruritus score of 10), the sensitivity and positive predictive value to detect an elevated bile acid level of X20 mmol/l was 50 and 60%, respectively ( Table 2) .
Univariate analysis comparing birth outcomes between ICP and normal subjects demonstrated no statistically significant differences with regards to mode of delivery, apgar scores, chorioamnionitis or presence of thick meconium, although there were clinical differences for both chorioamnionitis and meconium (Table 3) . Comparison of the mean birth weights between the two groups initially showed a statistically significant difference (3349.3 vs 3058.9 g, P ¼ 0.02); however, after controlling for gestational age there was no difference (Table 3) . Multiple logistic regression analysis to assess ICP as a predictor for obstetric outcomes demonstrated ICP having an association with chorioamnionitis (odds ratio (OR) 3.87, 95% CI 1.06 to 14.2) and a trend toward an association with the passage of thick meconium (OR 6.75, 95% CI 0.98 to 46.57) ( Table 4) .
The prevalence of ICP, birth outcomes and sensitivity analysis were performed using four diagnostic definitions for ICP:(1) any pruritus and bile acid level X15 mmol/l, (2) pruritus score >4 and bile acid level X15 mmol/l, (3) any pruritus and bile acid level X20 mmol/l and (4) pruritus score >4 and bile acid level X20 mmol/l. The latter three diagnostic definitions(2 to 4) all resulted in identical results. When ICP was defined as the presence of any itch and serum bile acid level X15 mmol/l, the prevalence increased to 7.1%. Univariate analysis demonstrated that this definition demonstrated a trend toward thick meconium passage (p ¼ 0.09); however, all other outcomes remained statistically nonsignificant when compared to normal subjects ( Table 5 ). The sensitivity, specificity, positive predictive value and negative predictive value were calculated for the pruritus scale at each categorical threshold using the different diagnostic criteria for ICP (Table 6 ). The pruritus scale had higher sensitivity and negative predictive values at the higher bile acid threshold of X20 mmol/l. The pruritus scale resulted with maximum sensitivity and negative predictive values with a pruritus score threshold of >4 for detecting ICP as defined as serum bile acid X20 mmol/l, which agrees with our original definition of ICP in this study. 11 Before this study, the prevalence of ICP in the United States had been reported to be on the order of 7/1000 and less than 1/1000 patients. 13, 14 Our comparatively higher prevalence (5.6%) could possibly be attributed to the primarily Latina patient population whom we serve. In 1998, 88% (3550/4046) of patients admitted to our obstetric service identified themselves as being Latina. 15 In 2000, 44.6% of people living in Los Angeles County were self-identified as being Latino in origin. 16 As described above, the prevalence of ICP is high in Latin America (Chile 4 to 22%, Bolivia 9%). The reasons for the geographic and ethnic disparities in the prevalence of the disease include genetic and environmental factors, although the former are thought to be much more important. 17 In our patient population, nearly one in five pregnancies is associated with pruritus score >4 in the third trimester. This observation is consistent with literature reporting the prevalence of pruritus in pregnancy. 18 Of those patients in our population Abbreviation: NPV, negative predictive value; PPV, positive predictive value. a Performance was the same when ICP was defined as pruritus score >4 and total serum bile acid concentration X15 or 20.
The prevalence of intrahepatic cholestasis of pregnancy RH Lee et al complaining of pruritus, 28% of patients have ICP. Although we did not find any statistically significant difference in preterm births, birthweights or apgars scores in our subjects, we were able to demonstrate ICP being a significant predictor for chorioamnionitis and a significant trend as a predictor for the passage of thick meconium. Given our relatively small number of subjects with ICP in this study, a larger study will need to be performed to avoid any type II error in these birth outcomes.
The primary strength of this investigation is the novelty in the observation that the prevalence of ICP is high in our patient population compared to other studies carried out in the United States. Furthermore, we have found that making a diagnosis of ICP on the basis of pruritus alone may lead to unnecessary intervention. Our data demonstrate when subjects complain of the most severe itching (pruritus score of 10); there is only a 60% positive predictive value for having an elevated bile acid level X20 mmol/l. A common clinical dilemma many clinicians face in Los Angeles is the 1 to 2 week turn around time for total serum bile acids to return. Our current clinical practice at LAC-USC is to deliver a patient with a known diagnosis of ICP once fetal lung maturity is reached. This lag time can be problematic to the clinician when faced with a patient who complains of severe itching at 36 to 37 weeks who is suspected of having ICP and a decision to proceed to delivery is needed. Our data demonstrate that potentially at least 40% of all deliveries for ICP made on pruritus alone may not have elevated bile acids. Thus, it is imperative that laboratories work in conjunction with clinicians to return bile acid levels more rapidly. On the other hand, our data also demonstrate that in the absence of itching, it is highly unlikely for a patient to have elevated total serum bile acids (negative predictive value ¼ 99.1%).
We acknowledge the limitations of our study: method of enrollment, lack of uniformity in obtaining fasting serum bile acid concentration, absence of liver function tests, use of a visual analog scale and criteria for ICP. The methodology of sampling our population was through convenience sampling. Our subjects were enrolled from only one hospital, during weekday work hours and invited to participate because they were accessible to our researchers. Convenience sampling lacks the randomness needed to apply prevalence data to an entire population. For instance, subjects with undiagnosed pruritus might have an inherent bias to participate when explained the study involved itching in pregnancy, and in the case of this study, this may falsely elevate the true prevalence of the disease. However, our data correlate well with our clinical observations that ICP is not uncommon in our population. Total serum bile acid concentrations are elevated twoto five-fold post-prandially and peak 30 to 90 min after meals. 19, 20 However, our data suggest the mean bile acid concentration in affected pregnancies is 15-fold higher than unaffected pregnancies and this effect is far above the variation that should be seen after a meal. We did not evaluate liver transaminases. Although liver transaminases can be elevated in ICP, total serum bile acid concentration appears to be the most specific laboratory evidence for the presence of ICP. 21, 22 To our knowledge, there is no validated method to measure pruritus in ICP. Our decision to use a 10-point visual analog scale was to provide our subjects an easy unidimensional method to rate their pruritus; pruritus is most commonly measured using a 10-point scale. 23 Furthermore, pruritus has been classified as a type of pain and many experts believe that itching can be assessed using a 10-point pain scale. 24 A pruritus score of greater than 4 was used as a criterion to diagnose ICP in this study to categorize only those subjects with relatively intense pruritus to have the disease. In addition, the receiver operating characteristic curve of our pruritus scale to predict an elevated bile acid level was good (area under the curve ¼ 0.897). Current literature has not uniformly agreed upon the criteria for ICP. Most studies use the combination of pruritus and elevated serum bile acid concentration 4, 25 as the defining criteria for ICP; however, the lower threshold for serum bile acid concentration and criteria for pruritus differ. In addition, other studies require the use of additional biochemical markers such as elevated transaminases as inclusion criteria for ICP. 26, 27 Rioseco et al. 28 diagnosed ICP based on clinical criteria alone. Our decision to use a total serum bile acid concentration of 20 mmol/l or greater is the highest threshold to our knowledge for the diagnosis of ICP.
In summary, the prevalence of ICP at our institution, which serves a primarily Latina population, is 5.6%. Although this statistic was obtained through convenience sampling, it correlates well with our clinical observation that ICP is fairly commonly seen in Los Angeles, California. More research is needed to elucidate the ethnic and geographic discrepancies seen in ICP. A uniform definition of the clinical and laboratory criteria for ICP needs to be established for both research and clinical purposes.
